‘I don’t know how much my wife earns’: I’m 63 with $6.4 million in stocks, mostly Apple. Will I get punished on taxes?
“Each of our properties are worth over $1 million.”
Wine and Stocks Thoughts about wine and stocks
My husband and I are splitting our estate between his child and my three children. Should they get equal shares?
“We try to help all our kids when we can, yet push for self-sufficiency.”
Rocket Lab’s stock blasts to a new high. Here’s what’s driving the surge.
The rocket-launch company just completed a government contract months ahead of schedule — and won a new one.
As stock-market rally broadens, it’s tough for the S&P 500 to keep advancing without tech
The S&P 500’s tech sector is down so far this month, even after its big rally on Friday.
Oracle’s stock is rising. Why TikTok’s U.S. deal could be good news for the tech company.
A memo from TikTok’s top executive reportedly says that the social-media phenomenon inked deals to create a U.S. joint venture, with Oracle’s cloud business as its backbone.
‘He never asks for anything’: I’m 61 with a $1.5 million 401(k). My girlfriend says I do too much for my son, 28. Is she right?
“I recently gave him $20,000 for a newer car and had him finance the rest.”
You’ve just won the $1.25 billion Powerball jackpot. Here are the 5 money moves you need to make next.
But even if you’re not a big lottery winner in Wednesday’s Powerball drawing, it’s still worth heeding this advice for managing a significant sum of money
It’s been illegal to make women have a man co-sign their loans since the ’70s. Now the Trump administration could change that.
Proposed changes to a rule barring banks from discriminating against certain borrowers are ‘alarming,’ and a ‘step backwards,’ consumer advocates say
Howard Stern and his 1 million listeners still have value for Sirius with contract extension
The terms of Stern’s deal were not disclosed, and while he commands a far smaller audience than in his heyday, it is still larger than most.
Pfizer’s stock drops after drug giant lowers its revenue forecast
The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year.
